openPR Logo
Press release

Parkinsons Disease Market to Significant Growth by 2030

08-18-2022 02:49 PM CET | Health & Medicine

Press release from: Acumen Research and Consulting

Acumen Research and Consulting has announced the addition of the "Parkinson's Disease Market" report to their offering.

The Parkinson's Disease Market Report 2030 is an in depth study analyzing the current state of the Parkinson's Disease Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Parkinson's Disease Market provides analysis of global market covering the industry trends, recent developments in the market and competitive landscape. Competitive analysis includes competitive information of leading players in global market, their company profiles, product portfolio, capacity, production, and company financials. In addition, report also provides upstream raw material analysis and downstream demand analysis along with the key development trends and sales channel analysis. Research study on Parkinson's Disease Market also discusses the opportunity areas for investors.

The report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Download Sample Report Copy From Here: https://www.acumenresearchandconsulting.com/request-sample/2435

Market Players as below:

Key companies profiled in this report involve Teva, Novartis AG, GSK, AbbVie, Merck, Boehringer Ingelheim, Impax Laboratories, Lundbeck, UCB, Valeant Pharmaceuticals, Acadia, and among others.

The major market segments of Parkinson's Disease Market are as below:

Market By Drug Class
Carbidopa/Levodopa
Dopamine receptor agonists
MAO-inhibitors
COMT-inhibitors
Anticholinergics
Other drugs

Market By Distribution Channel
Hospital Pharmacies
Retailer Pharmacies
Online Pharmacies

Market By Patient Care Setting
Hospitals
Clinics

Market By Geography

North America
• U.S.
• Canada

Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America
• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific
• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)
• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa

Ask Query Here: frank@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com

Table Of Contents:

CHAPTER 1. Industry Overview of Parkinson's Disease

CHAPTER 2. Research Approach

CHAPTER 3. Market Dynamics And Competition Analysis

CHAPTER 4. Manufacturing Plant Analysis

CHAPTER 5. Parkinson's Disease Market By Drug Class

CHAPTER 6. Parkinson's Disease Market Revenue By Distribution Channel

CHAPTER 7. Parkinson's Disease Market By Patient Care Setting

CHAPTER 8. North America Parkinson's Disease Market By Country

CHAPTER 9. Europe Parkinson's Disease Market By Country

CHAPTER 10. Asia Pacific Parkinson's Disease Market By Country

CHAPTER 11. Latin America Parkinson's Disease Market By Country

CHAPTER 12. Middle East & Africa Parkinson's Disease Market By Country

CHAPTER 13. Player Analysis Of Parkinson's Disease

CHAPTER 14. COMPANY PROFILE

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/2435

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parkinsons Disease Market to Significant Growth by 2030 here

News-ID: 2708700 • Views:

More Releases from Acumen Research and Consulting

Call Center AI Market to Reach USD 14.6 Billion by 2032 at 22.7% CAGR Driven by Chatbots and Omnichannel Automation
Call Center AI Market to Reach USD 14.6 Billion by 2032 at 22.7% CAGR Driven by …
What is the Call Center AI Market? The call center AI market represents a rapidly expanding segment of the global customer experience and enterprise automation industry focused on artificial intelligence technologies that enhance contact center operations through conversational automation, predictive analytics, and intelligent workflow orchestration. Call center AI solutions leverage technologies such as natural language processing (NLP), machine learning, speech recognition, and sentiment analysis to automate customer interactions and improve service
Distributed Control Systems Market to Reach USD 30.9 Billion by 2032 at 5.7% CAGR Driven by Industry 4.0 and Industrial Automation Growth
Distributed Control Systems Market to Reach USD 30.9 Billion by 2032 at 5.7% CAG …
What is the Distributed Control Systems Market? The distributed control systems market represents a critical segment of the global industrial automation industry focused on computerized control architectures that monitor and manage complex industrial processes across multiple controllers distributed throughout manufacturing facilities and process plants. Distributed control systems (DCS) enable real-time monitoring, operational coordination, and automation of large-scale industrial environments such as power plants, oil refineries, chemical facilities, and manufacturing operations. Unlike centralized
Cell Culture Market to Reach USD 47.7 Billion by 2032 at 11.1% CAGR Driven by Biologics and Regenerative Medicine Growth
Cell Culture Market to Reach USD 47.7 Billion by 2032 at 11.1% CAGR Driven by Bi …
What is the Cell Culture Market? The cell culture market represents a foundational segment of the global biotechnology and life sciences industry focused on technologies used to grow and maintain cells outside their natural biological environment under controlled laboratory conditions. Cell culture systems are essential across drug discovery, vaccine production, regenerative medicine, tissue engineering, diagnostics, and biopharmaceutical manufacturing workflows. Modern cell culture platforms include advanced media formulations, bioreactors, reagents, sera, and automated
Wheelchair Market to Reach USD 9.95 Billion by 2032 at 7.4% CAGR Driven by Electric Wheelchair Adoption and Aging Population
Wheelchair Market to Reach USD 9.95 Billion by 2032 at 7.4% CAGR Driven by Elect …
What is the Wheelchair Market? The wheelchair market represents a critical segment of the global assistive mobility devices industry focused on manual and powered mobility solutions designed to improve independence, accessibility, and quality of life for individuals with temporary or permanent mobility limitations. Wheelchairs are widely used across hospitals, rehabilitation centers, homecare environments, and long-term care facilities to support patients recovering from injuries, managing disabilities, or coping with age-related mobility challenges. Modern

All 5 Releases


More Releases for Parkinson

Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025? The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period? The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market? In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $1.43 billion
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%. Increasing Geriatric Population Driving Demand: The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,